<!-- mobian-agent-page publisher="dailydev" canonical="https://daily.dev/posts/huawei-plans-more-ai-pharma-partnerships-mainly-with-chinese-drugmakers-bybplntz6" -->

---
title: Huawei plans more AI pharma partnerships, mainly with...
description: Huawei's healthcare unit president William Zhang says the company plans more AI partnerships with pharmaceutical companies, mostly domestic Chinese drugmakers,...
canonical: https://daily.dev/posts/huawei-plans-more-ai-pharma-partnerships-mainly-with-chinese-drugmakers-bybplntz6
twitter:card: summary_large_image
twitter:site: @dailydotdev
og:type: website
og:site_name: daily.dev
og:title: Huawei plans more AI pharma partnerships, mainly with Chinese drugmakers | daily.dev
og:description: Huawei's healthcare unit president William Zhang says the company plans more AI partnerships with pharmaceutical companies, mostly domestic Chinese drugmakers,...
og:url: https://daily.dev/posts/huawei-plans-more-ai-pharma-partnerships-mainly-with-chinese-drugmakers-bybplntz6
og:image: https://api.daily.dev/og/posts/BybPLNtz6.png
og:image:alt: Huawei plans more AI pharma partnerships, mainly with Chinese drugmakers
og:image:width: 1200
og:image:height: 630
og:locale: en
---

> ## Documentation Index
> Fetch the complete documentation index at: https://daily.dev/llms.txt
> Use this file to discover all available pages before exploring further.

# Huawei plans more AI pharma partnerships, mainly with Chinese drugmakers

**[The Next Web](https://daily.dev/sources/tnw)** · 4 min read · 0 upvotes · 0 comments

## Summary

Huawei's healthcare unit president William Zhang says the company plans more AI partnerships with pharmaceutical companies, mostly domestic Chinese drugmakers, though no targets or new partners were named. The main cited example is a May deal with Guangzhou Pharmaceutical Holdings using StoneWise's AI drug models ported to Huawei's Ascend and Kunpeng chips — infrastructure work rather than original science. Huawei's own Pangu drug molecule model dates to 2021, and its Yunnan Baiyao tie-up to 2022, with neither producing a named drug candidate in trials. This is dwarfed by Nvidia's pharma partnerships, including a up to $1bn co-innovation lab with Eli Lilly, and Huawei's Ascend chips face US export restrictions limiting their addressable market outside China.

## Full article

daily.dev links to this article rather than hosting it. Read it at the original source: <https://thenextweb.com/news/huawei-ai-pharma-tie-ups-ascend-kunpeng>

## Questions this post answers

### What was Huawei's AI pharma deal with Guangzhou Pharmaceutical Holdings about?

Announced in May, it was described as the industry's first production validation of domestically developed AI drug research models adapted to Huawei's Ascend and Kunpeng chips. The actual AI models belong to StoneWise, a Beijing AI drug design company and third party to the agreement; Huawei's contribution was the silicon and porting the software onto it, not the underlying science.

_Track how domestic chip stacks are reshaping AI drug discovery partnerships on daily.dev._

### How does Huawei's AI pharma partnership scale compare to Nvidia's deals with Eli Lilly and Novo Nordisk?

Huawei's disclosed pharma work amounts to one three-party proof-of-concept agreement plus a four-year-old cooperation deal with Yunnan Baiyao, neither of which has produced a named drug candidate in trials. Nvidia, by contrast, has a co-innovation lab with Eli Lilly involving up to $1bn committed jointly over five years, alongside a separate partnership with Novo Nordisk.

_Compare AI chipmakers' real pharma traction before betting on a platform, on daily.dev._

### How many AI-discovered drugs have been approved so far, and how many are in clinical trials?

No AI-discovered drug has been approved anywhere yet, despite roughly $60bn invested globally in AI drug discovery. By June, 179 candidates were in pipelines compared to just four in 2017, and nine had reached Phase III trials. Industry forecasts suggest machine learning could halve early-stage development timelines and costs within three to five years.

_Follow how AI drug discovery pipelines are actually progressing, not just funded, on daily.dev._

## Similar posts on daily.dev

- [Huawei bid to build Egypt’s AI data centres, and Washington is scrambling](https://daily.dev/posts/huawei-bid-to-build-egypt-s-ai-data-centres-and-washington-is-scrambling-fkvljyxot) · The Next Web · 0 upvotes · 0 comments
- [Huawei Connect 2026: taking South African AI beyond pilots](https://daily.dev/posts/huawei-connect-2026-taking-south-african-ai-beyond-pilots-7ugolxoj0) · TechCentral · 0 upvotes · 0 comments
- [Huawei outlines industrial intelligence MWC 2026](https://daily.dev/posts/huawei-outlines-industrial-intelligence-mwc-2026-wo6c26gd7) · The Register · 0 upvotes · 0 comments
- [US export curbs push China's AI chips away from GPUs to custom ASICs](https://daily.dev/posts/us-export-curbs-push-china-s-ai-chips-away-from-gpus-to-custom-asics-cwhj4dhkn) · The Next Web · 1 upvotes · 0 comments

---

Tags: [#nvidia](https://daily.dev/tags/nvidia), [#healthcare](https://daily.dev/tags/healthcare), [#huawei](https://daily.dev/tags/huawei)

[View this post on daily.dev](https://daily.dev/posts/huawei-plans-more-ai-pharma-partnerships-mainly-with-chinese-drugmakers-bybplntz6)

```json
{"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://daily.dev/#organization","name":"daily.dev","url":"https://daily.dev","logo":{"@type":"ImageObject","url":"https://daily.dev/apple-touch-icon.png","width":180,"height":180},"sameAs":["https://twitter.com/dailydotdev","https://github.com/dailydotdev","https://www.linkedin.com/company/daily-dev-ltd"]},{"@type":"WebSite","@id":"https://daily.dev/#website","url":"https://daily.dev","name":"daily.dev","publisher":{"@id":"https://daily.dev/#organization"},"potentialAction":{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://daily.dev/search?q={search_term_string}"},"query-input":"required name=search_term_string"}}]}
{"@context":"https://schema.org","@type":"TechArticle","headline":"Huawei plans more AI pharma partnerships, mainly with Chinese drugmakers","url":"https://daily.dev/posts/huawei-plans-more-ai-pharma-partnerships-mainly-with-chinese-drugmakers-bybplntz6","mainEntityOfPage":{"@type":"WebPage","@id":"https://daily.dev/posts/huawei-plans-more-ai-pharma-partnerships-mainly-with-chinese-drugmakers-bybplntz6"},"datePublished":"2026-08-27T11:10:10.958Z","dateModified":"2026-08-27T11:10:35.041Z","description":"Huawei's healthcare unit president William Zhang says the company plans more AI partnerships with pharmaceutical companies, mostly domestic Chinese drugmakers,...","image":"https://media.daily.dev/image/upload/f_auto,q_auto/v1/posts/fb3c3355508cfe1158cec9d6f3aaba85?_a=AQAEuop","thumbnailUrl":"https://media.daily.dev/image/upload/f_auto,q_auto/v1/posts/fb3c3355508cfe1158cec9d6f3aaba85?_a=AQAEuop","isAccessibleForFree":true,"articleSection":"The Next Web","inLanguage":"en","publisher":{"@type":"Organization","name":"daily.dev","url":"https://daily.dev","logo":{"@type":"ImageObject","url":"https://daily.dev/apple-touch-icon.png","width":180,"height":180}},"author":{"@type":"Organization","name":"The Next Web","logo":"https://media.daily.dev/image/upload/t_logo,f_auto/v1/logos/tnw","url":"https://daily.dev/sources/tnw"},"commentCount":0,"discussionUrl":"https://daily.dev/posts/huawei-plans-more-ai-pharma-partnerships-mainly-with-chinese-drugmakers-bybplntz6","interactionStatistic":[{"@type":"InteractionCounter","interactionType":{"@type":"LikeAction"},"userInteractionCount":0},{"@type":"InteractionCounter","interactionType":{"@type":"CommentAction"},"userInteractionCount":0}],"keywords":"nvidia,healthcare,huawei","timeRequired":"PT4M"}
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://daily.dev"},{"@type":"ListItem","position":2,"name":"The Next Web","item":"https://daily.dev/sources/tnw"},{"@type":"ListItem","position":3,"name":"Huawei plans more AI pharma partnerships, mainly with Chinese drugmakers"}]}
{"@context":"https://schema.org","@type":"FAQPage","@id":"https://daily.dev/posts/huawei-plans-more-ai-pharma-partnerships-mainly-with-chinese-drugmakers-bybplntz6#faq","mainEntity":[{"@type":"Question","name":"What was Huawei's AI pharma deal with Guangzhou Pharmaceutical Holdings about?","acceptedAnswer":{"@type":"Answer","text":"Announced in May, it was described as the industry's first production validation of domestically developed AI drug research models adapted to Huawei's Ascend and Kunpeng chips. The actual AI models belong to StoneWise, a Beijing AI drug design company and third party to the agreement; Huawei's contribution was the silicon and porting the software onto it, not the underlying science. Track how domestic chip stacks are reshaping AI drug discovery partnerships on daily.dev."}},{"@type":"Question","name":"How does Huawei's AI pharma partnership scale compare to Nvidia's deals with Eli Lilly and Novo Nordisk?","acceptedAnswer":{"@type":"Answer","text":"Huawei's disclosed pharma work amounts to one three-party proof-of-concept agreement plus a four-year-old cooperation deal with Yunnan Baiyao, neither of which has produced a named drug candidate in trials. Nvidia, by contrast, has a co-innovation lab with Eli Lilly involving up to $1bn committed jointly over five years, alongside a separate partnership with Novo Nordisk. Compare AI chipmakers' real pharma traction before betting on a platform, on daily.dev."}},{"@type":"Question","name":"How many AI-discovered drugs have been approved so far, and how many are in clinical trials?","acceptedAnswer":{"@type":"Answer","text":"No AI-discovered drug has been approved anywhere yet, despite roughly $60bn invested globally in AI drug discovery. By June, 179 candidates were in pipelines compared to just four in 2017, and nine had reached Phase III trials. Industry forecasts suggest machine learning could halve early-stage development timelines and costs within three to five years. Follow how AI drug discovery pipelines are actually progressing, not just funded, on daily.dev."}}]}
```

